Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Why It Works: Modulates nitric oxide bioavailability at the eNOS level, helping stabilize the balance between vasodilation and vasoconstriction in injured tissue Upregulates VEGFR2 expression and drives VEGF-mediated angiogenesis, supporting new blood vessel formation at injury sites Protects cell-matrix adhesion through FAK-paxillin signaling and appears to dampen local inflammatory cascades via NF-B modulation Best For: Tendon, ligament, and soft-tissue injury recovery, along with gut-lining and gastrointestinal repair research Typical Protocol: Preclinical/research protocols commonly reference 200-500 mcg per day via subcutaneous injection, split into one or two daily doses (with 250 mcg once or twice daily being a frequently cited starting range)
Ozempic / Saxenda multi-dose pens, click here
This approach requires very careful monitoring by an experienced medical professional
J Endocrinol Invest 42:11251131 Paccou J, Yavropoulou MP, Naciu AM, Chandran M, Messina OD, Rolvien T, Carey JJ, Doronzo S, Anastasilakis AD, Saag KG, Lems WF (2024) Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society
US$ 26.09
US$ 28.46
US$ 26.74
US$ 27.81
US$ 26.53
US$ 20.77
US$ 25.51
US$ 27.15
US$ 25.43
